Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
The Unlikely Source of a Healthtech Revolution - Bloomberg
Teva Wins Appeal That Upholds Three Patents for Migraine Drug
Teva CEO Rejects Netanyahu Plea to Salvage Jerusalem Plant - Bloomberg
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On
Teva's job-cut tally could touch 10K: report | FiercePharma
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva Negotiating Sale of Remaining Women's Health Assets, Report Says | Ctech
Teva Gets Generic Drugmakers' Backing in Bid to Redo Label Case
Pfizer gets $2.15 billion settlement
Teva is on the prowl and its investors are taking notice
teva: Teva shows the flip side of rapidly growing corporate leverage - The Economic Times
New York jury holds drug firm Teva liable in opioid crisis
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva Must Face Amrix Developer's $97.5 Million Contract Suit
Israeli Drugmaker Teva in Talks to Help Produce Covid-19 Vaccines
Teva Pharmaeutical Stock Gets Upgrade From Analyst | Barron's
Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva CEO to Meet Netanyahu With Blunt Message on Need for Cuts - Bloomberg
Israel's Teva Buys Allergan's Generics Business For $40 Billion | Fortune
The Difficulties of Cloning a CEO - Bloomberg
Generic Makers to Challenge Ruling Upholding Teva Cancer Drug
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/OFHUIOHUNRDDZEATIQ3XXXHYQM.jpg "Teva to repay $1.2B for Cephalon's conspiring with generic firms")
Teva to repay $1.2B for Cephalon's conspiring with generic firms
Teva to Pay $85 Million Settlement in Oklahoma Opioid Case | Time
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva to Cut Up to 25% of Israel Workforce, Calcalist Says - Bloomberg
Opioid crisis: 4 pharmaceutical companies accused in the opioid epidemic reach a $260 million settlement just before trial | CNN
